Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total

Not Applicable (3)

Trial Status

Unknown3

Withdrawn1

Recruiting1

Completed1

Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT03898765Not ApplicableWithdrawn

Dry Blood Spot Screening Test for Biliary Atresia（DBS-SCReBA）

NCT07697872Recruiting

The Dirty Nappy Study

NCT06628726Not ApplicableNot Yet RecruitingPrimary

Liver Biopsy in Diagnosis Neonatal Jaundice

NCT06048211UnknownPrimary

Impact of the Stool Color Scale on the Detection of Neonatal Cholestasis

NCT03842150Unknown

Development and Validation of a Screening Score for the Biliary Atresia in Infantile Cholestasis: A Prospective Study

NCT05163145UnknownPrimary

Risk Factor for Cholestasis in Neonates Receiving TPN(Total Parenteral Nutrition)

NCT01875510Not ApplicableCompleted

The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities

Showing all 7 trials

Neonatal Cholestasis